Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Return on Sales (2021 - 2025)

PAVmed has reported Return on Sales over the past 5 years, most recently at 34.04% for Q4 2025.

  • Quarterly results put Return on Sales at 34.04% for Q4 2025, down 14824.0% from a year ago — trailing twelve months through Dec 2025 was 24.69% (down 854.0% YoY), and the annual figure for FY2025 was 24.69%, down 3418.0%.
  • Return on Sales for Q4 2025 was 34.04% at PAVmed, up from 1202.2% in the prior quarter.
  • Over the last five years, Return on Sales for PAVM hit a ceiling of 2527.5% in Q1 2021 and a floor of 2054.0% in Q2 2025.
  • Median Return on Sales over the past 5 years was 49.81% (2023), compared with a mean of 24.06%.
  • Biggest five-year swings in Return on Sales: plummeted -263138bps in 2022 and later soared 234620bps in 2025.
  • PAVmed's Return on Sales stood at 65.6% in 2021, then crashed by -234bps to 219.39% in 2022, then skyrocketed by 92bps to 16.59% in 2023, then soared by 788bps to 114.2% in 2024, then plummeted by -130bps to 34.04% in 2025.
  • The last three reported values for Return on Sales were 34.04% (Q4 2025), 1202.2% (Q3 2025), and 2054.0% (Q2 2025) per Business Quant data.